BNP Paribas Financial Markets
RLAY icon

BNP Paribas Financial Markets’s Relay Therapeutics RLAY Stock Holding History

BNP Paribas Financial Markets’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$545K Sell
29,119
-10,348
-26% -$150K ﹤0.01% 3710
2026
Q1 		$393K Buy
39,467
+19,463
+97% +$174K ﹤0.01% 3714
2025
Q4 		$169K Sell
20,004
-12,238
-38% -$87.3K ﹤0.01% 4130
2025
Q3 		$168K Sell
32,242
-3,199
-9% -$12.2K ﹤0.01% 4086
2025
Q2 		$123K Buy
35,441
+16,851
+91% +$50.1K ﹤0.01% 3946
2025
Q1 		$48.7K Sell
18,590
-221,078
-92% -$866K ﹤0.01% 4297
2024
Q4 		$987K Buy
+239,668
New +$1.3M ﹤0.01% 2837
2022
Q4 		– Sell
-103,147
Closed -$2.31M – 4500
2022
Q3 		$2.31M Buy
+103,147
New +$2.26M ﹤0.01% 1873

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Financial Markets's RLAY Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Relay Therapeutics (RLAY) stake by 26% in Q2 2026, selling an estimated $150K and leaving 29,119 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #3710.

BNP Paribas Financial Markets first reported a position in RLAY in Q3 2022 and has held it in 8 quarters since. The position peaked at $2.31M in Q3 2022. 241 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • BNP Paribas Financial Markets held 29,119 shares of Relay Therapeutics worth $545K as of Q2 2026.
  • BNP Paribas Financial Markets sold 10,348 Relay Therapeutics shares in Q2 2026, an estimated $150K.
  • Relay Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3710 holding.
  • BNP Paribas Financial Markets first reported a position in Relay Therapeutics in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Relay Therapeutics position peaked at $2.31M in Q3 2022.
  • 241 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.